GLOBAL MEDICAL ENZYMES MARKET 2022-2028
TABLE OF CONTENTS
1.
GLOBAL MEDICAL ENZYMES MARKET - SUMMARY
2.
INDUSTRY OUTLOOK
2.1.
IMPACT OF COVID-19 ON THE MEDICAL ENZYMES MARKET
2.2.
KEY INSIGHTS
2.2.1.
ADVANCEMENTS IN ENZYME ENGINEERING
2.2.2.
INCREASED DEMAND IN THE PHARMACEUTICAL SECTOR
2.3.
PORTER’S FIVE FORCES ANALYSIS
2.3.1.
THREAT OF NEW ENTRANTS
2.3.2.
THREAT OF SUBSTITUTES
2.3.3.
BARGAINING POWER OF BUYERS
2.3.4.
BARGAINING POWER OF SUPPLIERS
2.3.5.
THREAT OF COMPETITIVE RIVALRY
2.4.
KEY IMPACT ANALYSIS
2.4.1.
PRICE
2.4.2.
QUALITY
2.4.3.
USAGE
2.5.
MARKET ATTRACTIVENESS INDEX
2.6.
VENDOR SCORECARD
2.7.
INDUSTRY COMPONENTS
2.7.1.
RESEARCH AND DEVELOPMENT
2.7.2.
OPERATIONS
2.7.3.
OUTBOUND LOGISTICS
2.8.
REGULATORY FRAMEWORK
2.9.
KEY MARKET STRATEGIES
2.9.1.
MERGERS & ACQUISITIONS
2.9.2.
PRODUCT LAUNCHES & DEVELOPMENTS
2.9.3.
PARTNERSHIPS & AGREEMENTS
2.9.4.
BUSINESS EXPANSIONS & DIVESTITURES
2.10.
MARKET DRIVERS
2.10.1.
RISING INVESTMENTS IN RESEARCH AND DEVELOPMENT
2.10.2.
RISING AGING POPULATION AND OCCURRENCE OF CHRONIC DISEASES
2.10.3.
INCREASING APPLICATIONS IN THE PHARMACEUTICAL INDUSTRY
2.11.
MARKET CHALLENGES
2.11.1.
STRICT REGULATIONS
2.11.2.
SAFETY CONCERNS WHILE HANDLING ENZYMES
2.12.
MARKET OPPORTUNITIES
2.12.1.
RISING HEALTH ISSUES AND GROWING AWARENESS
2.12.2.
RISING DEMAND FOR SPECIALTY ENZYMES
3.
GLOBAL MEDICAL ENZYMES MARKET OUTLOOK - BY PRODUCT TYPE
3.1.
HYDROLASE
3.1.1.
HYALURONIDASE
3.1.2.
LYSOZYMES
3.1.3.
OTHER HYDROLASES ENZYMES
3.2.
THROMBOLYTIC ENZYME
3.2.1.
STREPTOKINASE
3.2.2.
UROKINASE
3.2.3.
OTHER THROMBOLYTIC ENZYMES
3.3.
DIGESTIVE ENZYME
3.3.1.
LACTASE
3.3.2.
L-ASPARAGINASE
3.3.3.
OTHER DIGESTIVE ENZYMES
3.4.
ENDONUCLEASE
3.4.1.
BENZONASE
3.4.2.
OTHER ENDONUCLEASES
4.
GLOBAL MEDICAL ENZYMES MARKET OUTLOOK - BY APPLICATION
4.1.
DISEASE TREATMENT
4.2.
DIAGNOSTIC TOOLS
4.3.
BIOMEDICAL RESEARCH
4.4.
OTHER APPLICATIONS
5.
GLOBAL MEDICAL ENZYMES MARKET – REGIONAL OUTLOOK
5.1.
NORTH AMERICA
5.1.1.
MARKET BY PRODUCT TYPE
5.1.1.1.
MARKET BY HYDROLASE
5.1.1.2.
MARKET BY THROMBOLYTIC
ENZYME
5.1.1.3.
MARKET BY DIGESTIVE ENZYME
5.1.1.4.
MARKET BY ENDONUCLEASE
5.1.2.
MARKET BY APPLICATION
5.1.3.
COUNTRY ANALYSIS
5.1.3.1.
UNITED STATES
5.1.3.2.
CANADA
5.2.
EUROPE
5.2.1.
MARKET BY PRODUCT TYPE
5.2.1.1.
MARKET BY HYDROLASE
5.2.1.2.
MARKET BY THROMBOLYTIC
ENZYME
5.2.1.3.
MARKET BY DIGESTIVE ENZYME
5.2.1.4.
MARKET BY ENDONUCLEASE
5.2.2.
MARKET BY APPLICATION
5.2.3.
COUNTRY ANALYSIS
5.2.3.1.
UNITED KINGDOM
5.2.3.2.
GERMANY
5.2.3.3.
FRANCE
5.2.3.4.
SPAIN
5.2.3.5.
ITALY
5.2.3.6.
REST OF EUROPE
5.3.
ASIA-PACIFIC
5.3.1.
MARKET BY PRODUCT TYPE
5.3.1.1.
MARKET BY HYDROLASE
5.3.1.2.
MARKET BY THROMBOLYTIC
ENZYME
5.3.1.3.
MARKET BY DIGESTIVE ENZYME
5.3.1.4.
MARKET BY ENDONUCLEASE
5.3.2.
MARKET BY APPLICATION
5.3.3.
COUNTRY ANALYSIS
5.3.3.1.
CHINA
5.3.3.2.
JAPAN
5.3.3.3.
INDIA
5.3.3.4.
SOUTH KOREA
5.3.3.5.
ASEAN COUNTRIES
5.3.3.6.
AUSTRALIA & NEW ZEALAND
5.3.3.7.
REST OF ASIA-PACIFIC
5.4.
LATIN AMERICA
5.4.1.
MARKET BY PRODUCT TYPE
5.4.1.1.
MARKET BY HYDROLASE
5.4.1.2.
MARKET BY THROMBOLYTIC
ENZYME
5.4.1.3.
MARKET BY DIGESTIVE ENZYME
5.4.1.4.
MARKET BY ENDONUCLEASE
5.4.2.
MARKET BY APPLICATION
5.4.3.
COUNTRY ANALYSIS
5.4.3.1.
BRAZIL
5.4.3.2.
MEXICO
5.4.3.3.
REST OF LATIN AMERICA
5.5.
MIDDLE EAST AND AFRICA
5.5.1.
MARKET BY PRODUCT TYPE
5.5.1.1.
MARKET BY HYDROLASE
5.5.1.2.
MARKET BY THROMBOLYTIC
ENZYME
5.5.1.3.
MARKET BY DIGESTIVE ENZYME
5.5.1.4.
MARKET BY ENDONUCLEASE
5.5.2.
MARKET BY APPLICATION
5.5.3.
COUNTRY ANALYSIS
5.5.3.1.
UNITED ARAB EMIRATES
5.5.3.2.
SAUDI ARABIA
5.5.3.3.
TURKEY
5.5.3.4.
SOUTH AFRICA
5.5.3.5.
REST OF MIDDLE EAST & AFRICA
6.
COMPETITIVE LANDSCAPE
6.1.
BASF SE
6.2.
DUPONT
6.3.
ROCHE HOLDING AG
6.4.
NOVOZYMES
6.5.
DSM
6.6.
SANOFI SA
6.7.
CODEXIS
6.8.
ADVANCED ENZYMES
6.9.
AMANO ENZYME
6.10.
BBI SOLUTIONS
6.11.
THERMOFISHER SCIENTIFIC INC
6.12.
CPC BIOTECH
6.13.
NOVUS
6.14.
BRAIN BIOTECH AG
6.15.
SEKISUI
7.
RESEARCH METHODOLOGY & SCOPE
7.1.
RESEARCH SCOPE & DELIVERABLES
7.2.
SOURCES OF DATA
7.3. RESEARCH METHODOLOGY
LIST OF TABLES
TABLE 1: GLOBAL MEDICAL ENZYMES MARKET, BY REGIONAL OUTLOOK, 2022-2028
(IN $ MILLION)
TABLE 2: APPLICATIONS OF ENZYMES IN THE PHARMACEUTICALS INDUSTRY
TABLE 3: VENDOR SCORECARD
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: LIST OF MERGERS & ACQUISITIONS
TABLE 6: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 7: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 8: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
TABLE 9: MEDICAL APPLICATION OF VARIOUS ENZYMES
TABLE 10: GLOBAL MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2022-2028 (IN
$ MILLION)
TABLE 11: GLOBAL MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2022-2028
(IN $ MILLION)
TABLE 12: GLOBAL MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME,
2022-2028 (IN $ MILLION)
TABLE 13: GLOBAL MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028
(IN $ MILLION)
TABLE 14: GLOBAL MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN
$ MILLION)
TABLE 15: GLOBAL MEDICAL ENZYMES MARKET, BY APPLICATION, 2022-2028 (IN $
MILLION)
TABLE 16: GLOBAL MEDICAL ENZYMES MARKET, BY REGIONAL OUTLOOK, 2022-2028
(IN $ MILLION)
TABLE 17: NORTH AMERICA MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028
(IN $ MILLION)
TABLE 18: NORTH AMERICA MEDICAL ENZYMES MARKET, BY PRODUCT TYPE,
2022-2028 (IN $ MILLION)
TABLE 19: NORTH AMERICA MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME,
2022-2028 (IN $ MILLION)
TABLE 20: NORTH AMERICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME,
2022-2028 (IN $ MILLION)
TABLE 21: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME,
2022-2028 (IN $ MILLION)
TABLE 22: NORTH AMERICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME,
2022-2028 (IN $ MILLION)
TABLE 23: NORTH AMERICA MEDICAL ENZYMES MARKET, BY APPLICATION,
2022-2028 (IN $ MILLION)
TABLE 24: EUROPE MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $
MILLION)
TABLE 25: EUROPE MEDICAL ENZYMES MARKET, BY PRODUCT TYPE 2022-2028 (IN $
MILLION)
TABLE 26: EUROPE MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2022-2028
(IN $ MILLION)
TABLE 27: EUROPE MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME,
2022-2028 (IN $ MILLION)
TABLE 28: EUROPE MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028
(IN $ MILLION)
TABLE 29: EUROPE MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME,
2022-2028 (IN $ MILLION)
TABLE 30: EUROPE MEDICAL ENZYMES MARKET, BY APPLICATION, 2022-2028 (IN $
MILLION)
TABLE 31: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN
$ MILLION)
TABLE 32: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY PRODUCT TYPE,
2022-2028 (IN $ MILLION)
TABLE 33: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME,
2022-2028 (IN $ MILLION)
TABLE 34: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME,
2022-2028 (IN $ MILLION)
TABLE 35: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME,
2022-2028 (IN $ MILLION)
TABLE 36: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME,
2022-2028 (IN $ MILLION)
TABLE 37: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY APPLICATION, 2022-2028
(IN $ MILLION)
TABLE 38: LATIN AMERICA MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028
(IN $ MILLION)
TABLE 39: LATIN AMERICA MEDICAL ENZYMES MARKET, BY PRODUCT TYPE,
2022-2028 (IN $ MILLION)
TABLE 40: LATIN AMERICA MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME,
2022-2028 (IN $ MILLION)
TABLE 41: LATIN AMERICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME,
2022-2028 (IN $ MILLION)
TABLE 42: LATIN AMERICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME,
2022-2028 (IN $ MILLION)
TABLE 43: LATIN AMERICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME,
2022-2028 (IN $ MILLION)
TABLE 44: LATIN AMERICA MEDICAL ENZYMES MARKET, BY APPLICATION,
2022-2028 (IN $ MILLION)
TABLE 45: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY COUNTRY,
2022-2028 (IN $ MILLION)
TABLE 46: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY PRODUCT
TYPE, 2022-2028 (IN $ MILLION)
TABLE 47: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY HYDROLASE
ENZYME, 2022-2028 (IN $ MILLION)
TABLE 48: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC
ENZYME, 2022-2028 (IN $ MILLION)
TABLE 49: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY DIGESTIVE
ENZYME, 2022-2028 (IN $ MILLION)
TABLE 50: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE
ENZYME, 2022-2028 (IN $ MILLION)
TABLE 51: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY APPLICATION,
2022-2028 (IN $ MILLION)
LIST OF FIGURES
FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: GLOBAL MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2021 &
2028 (IN %)
FIGURE 5: GLOBAL MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2028 (IN $
MILLION)
FIGURE 6: GLOBAL MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2021 &
2028 (IN %)
FIGURE 7: GLOBAL MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2028 (IN
$ MILLION)
FIGURE 8: GLOBAL MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2028 (IN $
MILLION)
FIGURE 9: GLOBAL MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES,
2022-2028 (IN $ MILLION)
FIGURE 10: GLOBAL MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME,
2022-2028 (IN $ MILLION)
FIGURE 11: GLOBAL MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2021
& 2028 (IN %)
FIGURE 12: GLOBAL MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2028
(IN $ MILLION)
FIGURE 13: GLOBAL MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2028 (IN $
MILLION)
FIGURE 14: GLOBAL MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES,
2022-2028 (IN $ MILLION)
FIGURE 15: GLOBAL MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028
(IN $ MILLION)
FIGURE 16: GLOBAL MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2021
& 2028 (IN %)
FIGURE 17: GLOBAL MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2028 (IN $
MILLION)
FIGURE 18: GLOBAL MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2028
(IN $ MILLION)
FIGURE 19: GLOBAL MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES,
2022-2028 (IN $ MILLION)
FIGURE 20: GLOBAL MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN
$ MILLION)
FIGURE 21: GLOBAL MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, 2021
& 2028 (IN %)
FIGURE 22: GLOBAL MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2028 (IN $
MILLION)
FIGURE 23: GLOBAL MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES,
2022-2028 (IN $ MILLION)
FIGURE 24: GLOBAL MEDICAL ENZYMES MARKET, BY APPLICATION, 2021 &
2028 (IN %)
FIGURE 25: GLOBAL MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT,
2022-2028 (IN $ MILLION)
FIGURE 26: GLOBAL MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2028
(IN $ MILLION)
FIGURE 27: GLOBAL MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH,
2022-2028 (IN $ MILLION)
FIGURE 28: GLOBAL MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS,
2022-2028 (IN $ MILLION)
FIGURE 29: GLOBAL MEDICAL ENZYMES MARKET, REGIONAL OUTLOOK, 2021 &
2028 (IN %)
FIGURE 30: UNITED STATES MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 31: CANADA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 32: UNITED KINGDOM MEDICAL ENZYMES MARKET 2022-2028 (IN $
MILLION)
FIGURE 33: GERMANY MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 34: FRANCE MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 35: SPAIN MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 36: ITALY MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 37: REST OF EUROPE MEDICAL ENZYMES MARKET 2022-2028 (IN $
MILLION)
FIGURE 38: CHINA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: JAPAN MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 40: INDIA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 41: SOUTH KOREA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 42: ASEAN COUNTRIES MEDICAL ENZYMES MARKET 2022-2028 (IN $
MILLION)
FIGURE 43: AUSTRALIA & NEW ZEALAND MEDICAL ENZYMES MARKET 2022-2028
(IN $ MILLION)
FIGURE 44: REST OF ASIA-PACIFIC MEDICAL ENZYMES MARKET 2022-2028 (IN $
MILLION)
FIGURE 45: BRAZIL MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 46: MEXICO MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 47: REST OF LATIN AMERICA MEDICAL ENZYMES MARKET 2022-2028 (IN $
MILLION)
FIGURE 48: UNITED ARAB EMIRATES MEDICAL ENZYMES MARKET 2022-2028 (IN $
MILLION)
FIGURE 49: SAUDI ARABIA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 50: TURKEY MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 51: SOUTH AFRICA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 52: REST OF MIDDLE EAST & AFRICA MEDICAL ENZYMES MARKET
2022-2028 (IN $ MILLION)
Rising health awareness to increase demand for
medical enzymes
MARKET OUTLOOK
As per Triton’s market report, the global medical enzymes market is
estimated to progress with a CAGR of 6.78% during the forecast period
2022-2028.
Factors such as rising investments in R&D, a growing aging
population, and a high incidence of chronic diseases are fueling the studied
market’s growth. The rising applications of medical enzymes in the
pharmaceutical industry are expected to widen the market’s scope.
However, stringent regulation and safety concerns while handling enzymes
are major factors negatively impacting the medical enzymes market’s
progression.
Get more insights into the
Global Medical Enzymes Market:
https://www.tritonmarketresearch.com/reports/medical-enzymes-market
REGIONAL OUTLOOK
The global medical enzymes market covers Latin America, Europe, North
America, Asia-Pacific, and the Middle East and Africa.
Globally, the Asia-Pacific is deemed to emerge as the fastest-growing
region over the forecast period. The growing weight and digestive disorders are
estimated to increase the demand for enzymes. Moreover, the growing health
awareness is expected to support the demand for digestive enzymes across the region.
Abnormalities in enzyme metabolism lead to various diseases that are likely to
fuel the medical enzymes market. Besides this, the rising sports activities are
anticipated to drive the studied market on a growth path.
COMPETITIVE OUTLOOK
The prominent companies in the medical enzymes market are BASF SE,
Dupont, Roche Holding AG, Novozymes, DSM, Sanofi SA, Codexis, Advanced Enzymes,
Amano Enzyme, BBI Solutions, Thermofisher Scientific Inc, CPC Biotech, Novus,
Brain Biotech AG, and Sekisui.
BASF SE operates over 232 production sites across the globe. Its
customers include small, medium, and large organizations. It operates through
six business segments classified as chemicals, materials, industrial solutions,
surface technologies, nutrition and care, and agricultural solutions. The
company serves clients across numerous industries. BASF has headquarters
located in Germany.
SEGMENTATION
1.
BASF SE
2.
DUPONT
3.
ROCHE HOLDING AG
4.
NOVOZYMES
5.
DSM
6.
SANOFI SA
7.
CODEXIS
8.
ADVANCED ENZYMES
9.
AMANO ENZYME
10.
BBI SOLUTIONS
11.
THERMOFISHER SCIENTIFIC INC
12.
CPC BIOTECH
13.
NOVUS
14.
BRAIN BIOTECH AG
15. SEKISUI
Comments
Post a Comment